Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations
K. Jane Grande-Allen, PhD*,
Brian P. Griffin, MD, FACC ,
Norman B. Ratliff, MD ,
Delos M. Cosgrove, III, MD and
Ivan Vesely, PhD*,*
* Biomedical Engineering, The Cleveland Clinic Foundation,, Cleveland, Ohio USA
Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio USA
Anatomic Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio USA
Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

View larger version (34K):
[in a new window]
|
Figure 2 Concentrations of individual glycosaminoglycan (GAG) classes. C-0-S = unsulfated chondroitin; C-4-S = chondroitin-4-sulfate; C-6-S = chondroitin-6-sulfate; D-4-S = dermatan-4-sulfate; D-6-S = dermatan-6-sulfate; HA = hyaluronan; XS = oversulfated chondroitin/dermatan sulfate. *p < 0.05, chordae versus leaflets; p < 0.05, unileaflet prolapse (ULP) or bileaflet prolapse (BLP) versus normal.
|
|

View larger version (53K):
[in a new window]
|
Figure 3 Proportions of different glycosaminoglycan classes. C-0-S = unsulfated chondroitin; C-4-S = chondroitin-4-sulfate; C-6-S = chondroitin-6-sulfate; D-4-S = dermatan-4-sulfate; D-6-S = dermatan-6-sulfate; HA = hyaluronan; XS = oversulfated chondroitin/dermatan sulfate.*p < 0.05, unileaflet prolapse (ULP) or bileaflet prolapse (BLP) versus normal.
|
|
|